REQUEST A DEMO
Total
USD $0.00
Search more companies

Tamin Pharmaceutical Investment Company Public Joint Stock (تامين الاستثمارية للدواء) (Iran)

Main Activities: Securities, Commodity Contracts, and Other Financial Investments and Related Activities
Full name: Tamin Pharmaceutical Investment Company Public Joint Stock Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Tamin Pharmaceutical Investment Company Public Joint Stock (تامين الاستثمارية للدواء) is a company based in Iran, with its head office in Tehran. The enterprise operates in the Securities, Commodity Contracts, and Other Financial Investments and Related Activities industry. It was established on April 04, 2026. Tamin Pharmaceutical Investment Company Public Joint Stock (تامين الاستثمارية للدواء) currently employs 11,237 (2024) people. There was a total growth of 30.1% in Tamin Pharmaceutical Investment Company Public Joint Stock (تامين الاستثمارية للدواء)’s total assets over the same period.

Headquarters
Valie Asr St, No.81- West Nahid St. - Opposite To Mellat Park
Tehran; Tehran; Postal Code: 1966913481

Contact Details: Purchase the Tamin Pharmaceutical Investment Company Public Joint Stock (تامين الاستثمارية للدواء) report to view the information.

Website: http://www.tpicoholding.com

Basic Information
Total Employees:
Purchase the Tamin Pharmaceutical Investment Company Public Joint Stock (تامين الاستثمارية للدواء) report to view the information.
Outstanding Shares:
Purchase the Tamin Pharmaceutical Investment Company Public Joint Stock (تامين الاستثمارية للدواء) report to view the information.
Financial Auditors:
Purchase the Tamin Pharmaceutical Investment Company Public Joint Stock (تامين الاستثمارية للدواء) report to view the information.
Incorporation Date:
April 04, 2026
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
41.56%
Purchase this report to view the information.
17.5%
Purchase this report to view the information.
14.51%
Purchase this report to view the information.
6.74%
Purchase this report to view the information.
3.18%
Subsidiaries
Awzan
100%
Research And Engineering Tawfek Daru
100%
Sima Iranian Health Salamat
100%
Company Performance
Financial values in the chart are available after Tamin Pharmaceutical Investment Company Public Joint Stock (تامين الاستثمارية للدواء) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Total Operating Revenue
-90.65%
Operating Profit
-14.48%
EBITDA
-12.2%
Net Profit/Loss for the Period
N/A
Total Assets
30.1%
Total Equity
23.27%
Return on Equity (ROE)
N/A
Quick Ratio
-111.39%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?